Navigation Links
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
Date:7/14/2008

MOUNTAIN VIEW, Calif., July 14 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced it has initiated its Phase 3 clinical program to evaluate MAP0004 as a potential treatment for migraine.

MAP0004 is orally inhaled and self-administered at home using MAP Pharmaceuticals' proprietary Tempo(R) inhaler. In the company's prior Phase 2 efficacy study, MAP0004 provided pain relief in as fast as 10 minutes, with relief sustained through at least 24 hours. The study also demonstrated efficacy trends in treating nausea, photophobia and phonophobia, the other key measurements in treating migraine.

This randomized, double-blind, placebo-controlled Phase 3 trial is designed to evaluate the efficacy and safety of MAP0004 in treating acute migraine. The primary efficacy endpoints will be pain relief, and freedom from nausea, photophobia and phonophobia as measured at two hours after dosing. MAP will also evaluate earliest onset of pain relief and sustained relief to 24 and 48 hours. The multi-center efficacy trial will include approximately 850 patients, who will also be followed for 12 months in an open-label study to confirm long-term safety.

"We believe that MAP0004 has the potential to be a first-line therapy for migraine patients," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals. "Based on our initial clinical studies, we believe that MAP0004 offers an alternative to triptans that may provide patients with the benefits of rapid onset and long-lasting pain relief, in an easy-to-use, non-invasive, at-home therapy. In our Phase 2 trials, MAP0004 was well tolerated with no effect on pulmonary function, including in asthmatic subjects."

The therapeutic agent
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sony Biotechnology Inc. ("Sony") today announced the launch of ... sorting chip.  Sony will also be exhibiting its newly rebranded ... Sorter, the EC800 flow cytometer, and new SP6800 Spectral Analyzer ... will be held at the San Diego ... , from May 20 - 22.  The ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group has ... their competitive landscape map for the Chronic Kidney ... 90 international companies with drugs and devices currently ... and its sequelae. (Logo:  ... , hypertension - renal denervation , ...
(Date:5/17/2013)... 2013 Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ... developing new, patent-pending technologies poised to redefine how consumers receive ... hold a business update teleconference and webcast for shareholders and ... at 4:30 PM ET. Fuse Science, Inc. ... call and will be joined by Rubin Hanan ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... Chance, as international counsel, has advised Pfizer on the conditional ... The clearance was issued by the Ministry of Commerce (MOFCOM) ... authorities was one of the key conditions of the Pfizer/Wyeth ... deal; decisions are awaited from the Australian, Canadian and US ...
... EMD Serono, Inc. an affiliate of Merck ... New Drug Application (NDA) to the US Food and ... investigational oral formulation of cladribine, as a therapy for ... sclerosis (MS). Cladribine Tablets has the potential to be ...
Cached Medicine Technology:Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 2EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States 2EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States 3EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States 4
(Date:5/19/2013)... 19, 2013 Today, Zane Benefits, ... business health insurance . Zane Benefits, which provides ... health benefits, is the leader in health care ... reimbursement arrangements . , According to Zane Benefits’ ... intrinsically know the value of small business health ...
(Date:5/19/2013)... 2013 6Webs.com is the leader in ... who are considering an alarm system can do a ... leading security system providers online at 6Webs.com. Just recently ... DIY home security system companies, 6Webs.com currently is ... of home security companies before ranking the home security ...
(Date:5/19/2013)... 19, 2013 Fat Burning Furnace developed ... that provides people with fat burning diet ... this Fat Burning Furnace package, people will receive the ... can download quickly. The Fat Burning Furnace manual includes ... build lean muscle mass. In addition, this book covers ...
(Date:5/19/2013)... 2013 Farming methods have changed many ... ground 10,000 years ago. Most recently, the Green Revolution ... using genetically engineered seeds and by applying chemical fertilizers ... to these techniques due to the adverse environmental and ... corresponding surge in interest in organic, sustainable farming practices ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Vegas Hotel ... is proud to announce the launch it's all new ... the MGM Grand on 5/19/2013. Consumers traveling to Las ... special pricing available on VegasHotelEscapes.com's website. Travelers will be ... beat any competitors price. , Vegas Hotel Escapes specializes ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3
... ... and scars which could help up to 23 million women , ... (PRWEB) May 30, 2010 -- The Harley Medical Group has announced that ... market, which promises to reduce the appearance of stretch marks, medically termed striae, and scars by ...
... ... Raising chickens in the backyard is growing more popular as Americans ... backyard chickens increases, so does the need to educate owners about keeping ... Plant Health Inspection Service’s (USDA/APHIS) Biosecurity for Birds campaign is renewing its ...
... ... compliance wherever PCs are located , ... (PRWEB) June 2, 2010 -- Beachhead Solutions Inc. announced today the ... Managed Service Providers (MSPs). For those organizations affected by the new laws requiring encryption ...
... As part of a national clinical trial, UT Southwestern ... two popular treatments for one of the most common ... incontinence affects up to 50 percent of women in ... with stress incontinence experience leakage during increases in abdominal ...
... one-size-fits-all medicine will eventually be history; after all it is ... same for everyone. For patients with nonsmall cell lung ... people annually, the treatment currently available is basically the same ... respond to treatment while others may not. New biological markers ...
... effects linked to taking too much supplemental calcium are ... an upcoming issue of the Journal of the ... so-called milk-alkali or calcium-alkali syndrome is growing in large ... vitamin D supplements. The milk-alkali syndrome arose in ...
Cached Medicine News:Health News:The Harley Medical group launches exclusive treatment for stretch marks and scars 2Health News:The Harley Medical group launches exclusive treatment for stretch marks and scars 3Health News:Backyard Poultry A Growing Trend Throughout US - USDA Offers Pointers on Keeping them Safe, 2Health News:Backyard Poultry A Growing Trend Throughout US - USDA Offers Pointers on Keeping them Safe, 3Health News:PC Encryption Compliance Delivered Through The Cloud Now Available As Simple Monthly Service For Business 2Health News:PC Encryption Compliance Delivered Through The Cloud Now Available As Simple Monthly Service For Business 3Health News:UT Southwestern investigators perform head-to-head comparison of incontinence treatments 2Health News:A prognostic and predictive biomarker for nonsmall cell lung cancer 2Health News:Calcium supplements: too much of a good thing? 2
... GORE SEAMGUARD® Staple Line Reinforcement ... in reducing postoperative pulmonary air leaks ... hospital care. This inert, biocompatible, ePTFE ... non-biological.,It is easy to load and ...
... for the repair of abdominal hernias. It ... two distinct sides. One side of ... of sodium hyaluronate and carboxymethylcellulose (similar to ... side is bioresorbable, providing a temporary physical ...
... Company, we recognize that there are circumstances ... in-growth between the prosthesis and the repair ... all the products in Bards complete line ... proven, versatile repair.,The Reconix Patch is Bards ...
... PLUS Biomaterial is the first hernia ... controlling potential operative contamination of the ... two antimicrobial preservative agents, silver carbonate ... inhibit bacterial colonization on the patch ...
Medicine Products: